Kate Goodrich, a theme lead for AcademyHealth’s Annual Research Meeting, highlights key research from the theme Payment and Delivery System Innovation that will be presented at the conference June 4-7.
There are numerous obstacles to consumer price shopping in health care and shifting patients’ behavior has been difficult. Recently, some insurers have used financial rewards to get beneficiaries to use lower-priced providers. In this ‘plain language summary,’ new research indicates the strategy may have some affect, although overall impacts of the program are modest.
AcademyHealth and the National Pharmaceutical Council (NPC) consider the drivers of health spending in the U.S. through salons focused on challenging questions. Today’s post takes a closer look at how the macro health economy may evolve post-pandemic.
The annual Reinhardt Lecture honors a national leader who reflects the high standards of Professor Uwe Reinhardt. The 2021 lecturer was Dr. Sherry Glied, who honored Dr. Reinhardt’s trailblazing focus on price, rather than quantity, with a discussion of the role of price as a market signal. The following plain language summary offers highlights from the transcribed remarks, as delivered at the virtual 2021 Annual Research Meeting and published in the journal Health Services Research.
As the Centers for Medicare and Medicaid Services (CMS) moves to strengthen its price transparency efforts, a panel of experts recently discussed what advancements are necessary to provide consumers with accurate, useful information to make informed decisions about the cost and quality of care.
This webinar covered the impact of price transparency reporting thus far. Panelists discussed what additional efforts are necessary to provide consumers with accurate information to make more informed decisions.
Date & Time October 6, 2021, 12:00 p.m. - 1:00 p.m. ET
Lack of data regarding dual-eligible individuals has long hindered the development of effective policy solutions and care improvement. AcademyHealth organizational member Arnold Ventures highlights new resources to help the research community strengthen and expand evidence at a critical time in the policy debate.
As lead clinicians for their states with responsibility for overseeing clinical care and stewardship of resources, Medicaid Medical Directors share their perspectives on clinical matters related to the FDA’s Accelerated Approval Program.
A recent literature review revealed most studies of social need interventions were poorly designed, inadequately documented, and inconsistently presented. In this post, Robert Dubois of the National Pharmaceutical Council, an AcademyHealth Organizational Member, outlines the state of the research and provides recommendations to improve study design quality.